Exciting early data for new highly selective TYK2i zasocitinib Improved PASI skin scores (though not as much as IL23i..
Tweet Content
Exciting early data for new highly selective TYK2i zasocitinib
Improved PASI skin scores (though not as much as IL23i...)
Funky skin-related adverse events at higher doses, not sure what to make of that?
#ACR24 @rheumnow Abstr#1477 https://t.co/CtOFsoHdBh
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off